COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE

COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

PYRIDINE CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF

ROCK2 Inhibitors And Uses Thereof

LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANIC COMPOUND

FUNCTIONAL OLIGOMERS AND FUNCTIONAL POLYMERS INCLUDING HYDROXYLATED POLYMERS AND CONJUGATES THEREOF AND USES THEREOF

PHENYL OXY AMIDE KINASE INHIBITORS

HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF

IMIDAZOLYL-AMINO-PYRAZINE-CARBONITRILS AS CHK-1 INHIBITORS

PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS

COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES

INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF

COMPOUNDS

METHODS FOR TREATING CANCER

TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS

HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS

PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS

GIP RECEPTOR AGONIST COMPOUNDS

POLO LIKE KINASE 4 INHIBITORS

LIGHT-RECEIVING DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS

ULK3 INHIBITORS AND USES THEREOF

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

METALLOENZYME INHIBITOR COMPOUNDS

GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF

FUSED RING COMPOUND AND PHARMACEUTICAL CONTAINING SAME

KHK INHIBITORS

PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS

BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF

NOVEL COMPOUNDS AS CK2 INHIBITORS

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF

ANTI-VIRAL COMPOUNDS

TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES

LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS

BENZOYLFORMIC ACID AMIDE DERIVATIVE

DDR1 AND DDR2 INHIBITORS FOR THE TREATEMENT OF CANCER AND FIBROTIC DISEASES

KINASE INHIBITORS

KCC2 POTENTIATORS AND USES THEREOF

SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME

SUBSTITUTED HETEROCYCLES AS RAS INHIBITORS

VISIBLE LIGHT SENSITIVE PHOTOREMOVABLE PROTECTING GROUPS, PREPARATION PROCESS THEREOF, PHOTOACTIVATABLE CONJUGATES COMPRISING THEM AND USES THEREOF

TRIAZINE COMPOUNDS AND USES THEREOF

INHIBITORS OF LRRK2 KINASE

PYRROLIDINE COMPOUNDS

HYDROQUINAZOLINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

INHIBITORS OF RAF KINASES

PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS

HETEROCYCLIC INHIBITORS OF MCT4

ANTIBACTERIAL COMPOUNDS

HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF MUTANT KRAS PROTEIN

PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF

ALKYNYL QUINAZOLINE COMPOUNDS

HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF G12V MUTANT KRAS PROTEIN

TRIARYL AGONISTS OF ALPHA-2 ADRENERGIC RECEPTORS

PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS

GPR6 INVERSE AGONISTS

Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer

INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

INHIBITORS OF MYC AND USES THEREOF

HERBICIDAL IMIDAZOLE COMPOUNDS

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

TREATMENT OF GVHD

JAK1 SELECTIVE INHIBITORS

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF

COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS

CELL-PERMEANT COVALENT INHIBITORS OF VIRAL CYSTEINE PROTEASES

DIARYLACETYLENE COMPOUND, PREPARATION METHOD THEREOF, AND USES THEREOF

5-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE

COMPOUNDS AS GLP-1R AGONISTS

ATM KINASE INHIBITORS

PYRIDAZINE BASED SMALL MOLECULE INHIBITOR OF COGNITIVE IMPAIRMENT

UREA DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

AMINOPYRIMIDINYL DERIVATIVES FOR THE TREATMENT OF PARKINSON'S DISEASE

TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D

ANTIBACTERIAL COMPOUNDS

HETEROCYCLIC COMPOUND CAPABLE OF INHIBITING PRMT5-MTA AND USE THEREOF

QUENCHER AND USES THEREOF

Substituted N-(Pyridin-2-yl)Acetamide Derivatives as CDK12/13 Inhibitors

HETEROCYCLIC COMPOUND FOR INHIBITING AND/OR INDUCING DEGRADATION OF KRAS PROTEIN

SELECTIVE G PROTEIN-COUPLED RECEPTOR KINASE 5 INHIBITORS, COMPOSITIONS, AND METHODS OF USE

AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS

SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF

Compounds for treatment a coronavirus infection

COMPOUNDS AND COMPOSITIONS FOR EYE TREATMENTS

METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES

PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS

BRANCHED MULTI-FUNCTIONAL MACROMONOMERS AND RELATED POLYMERS AND USES THEREOF

PROTEIN DEGRADERS AND USES THEREOF

1,4-DIPHENYL-1H-INDAZOLE AND 1-PYRIDIN-2-YL-4-PHENYL-1H-INDAZOLE DERIVATIVES AS PD-1/PD-L1 MODULATORS FOR THE TREATMENT OF CANCER

SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS

ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS

COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES

BICYCLIC AMINE CDK12 INHIBITORS

DPP9 BINDING COMPOUNDS

INTERLUKIN-17A INHIBITORS AND USES THEREOF

SUBSTITUTED HETEROCYCLIC COMPOUND DERIVATIVES AND THEIR PHARMACEUTICAL USE

ROCK INHIBITORS AND USES THEREOF

NITROGEN-CONTAINING FIVE-MEMBERED HETEROCYCLIC DERIVATIVES AS CHECKPOINT KINASE 1 INHIBITOR AND USES THEREOF

NOVEL PYRIMIDINYL SULFONAMIDE DERIVATIVES

PYRIDAZINONE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF

BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS

KCNT1 INHIBITORS COMPRISING A PYRAZOLE CORE AND METHODS OF USE

Next Generation Synthetic Transcription Factors

THYROID HORMONE RECEPTOR AGONISTS

IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4

PHARMACEUTICALLY ACTIVE COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING PENDRIN

Heterocyclic Compounds as Immunomodulators of PD-L1 Interactions

HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT

ANTAGONISTS OF GPR39 PROTEIN

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

MONOARYL AND HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT

COMPOUNDS AND METHODS FOR MODULATING SPLICING

DENDRON-LIKE LIPID COMPOUND, LIPOSOME, LIPID COMPLEX, AND LIPID NANOPARTICLE AND USE THEREOF

INHIBITORS OF THE MENIN-MLL INTERACTION

LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE

COMPOUNDS AND METHODS FOR MODULATING SPLICING

THERAPEUTIC COMPOUNDS

4-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

NUCLEIC ACID BINDERS

LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND

PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE

MODULATORS OF THR-BETA AND METHODS OF USE THEREOF

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

Ether-Linked Antiviral Compounds

ASK1 INHIBITOR COMPOUNDS AND USES THEREOF

HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME

OPHTHALMIC DEVICES

Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease

CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES

COMPOUNDS USEFUL FOR GOUT

Inhibitors of ROCK2

COMPOUNDS FOR PROLIFERATIVE DISORDERS

INDOLE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF

TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER

PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE

THERAPEUTIC COCRYSTALS OF 3-{[5-(AZETIDINE-1-YLCARBONYL)PYRAZIN-2-YL]OXY}-5-{[(1S)-1-METHYL-2-(METHYLOXY)ETHYL]OXY)-N-(5-METHYLPYRAZIN-2-YL)BENZAMIDE

PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS

INHIBITORS OF TAU PROTEINS

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

GLP-1 Receptor Agonists and Uses Thereof

PD-1/PD-L1 INHIBITORS

Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto

COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY

KRAS INHIBITORS

TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE

COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS

TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE

SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

COMPOSITIONS AND METHODS FOR INHIBITING KINASES

LRRK2 Inhibitors

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES

HERBICIDAL IMIDAZOLE-CONTAINING COMPOUNDS

METHIONINE ADENOSYLTRANSERASE 2A INHIBITORS

ANTI-VIRAL COMPOUNDS

COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS

sGC STIMULATORS

QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE

COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF

Dry Film Resist, Photosensitive Dry Film, and Copper Clad Laminate

RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE

PYRAZOLE COMPOUNDS AND USES THEREOF

EGFR INHIBITORS

LACTAMS AS CBL-B INHIBITORS

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

Substituted Fused Bicyclic Compounds and Related Methods of Treatment

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME

PYRAZINAMIDE COMPOUNDS

COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF

BENZIMIDAZOLE HETEROATOM-CONTAINING SPIRO COMPOUND AND MEDICINAL USE THEREOF

PEPTIDYL FLAVOR MODIFIERS

QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS

PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

STAT6 INHIBITORS AND USES THEREOF

PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, COMPOUND, AND MANUFACTURING METHOD OF COMPOUND

HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN

COMPOSITIONS AND METHODS FOR TREATING CANCER

BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS

SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS

2,4-DIOXOTETRAHYDROPYRIMIDINYL DERATIVES AS DEGRONS IN PROTACS

CLICK-CHEMISTRY FUNCTIONALIZED COMPOUNDS AND METHODS OF CONJUGATION

HETEROARYL COMPOUNDS FOR TREATMENT OF COMPLEMENT FACTOR D MEDIATED DISORDERS

SMALL MOLECULE MODULATORS OF IL-17

PYRAZINE AMIDE DERIVATIVES

CDK2 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

TRIAZINE COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

POLYMORPHIC FORMS OF KINASE INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, PREPARATION METHOD THEREFOR AND USE THEREOF

TRIAZINE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

NOVEL COMPOUND AND USE THEREOF FOR INHIBITING CHECKPOINT KINASE 2

NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

SPLEEN TYROSINE KINASE INHIBITOR, COMPOSITION, AND METHODS OF USE

ORGANIC LIGHT-EMITTING ELEMENT, METHOD FOR EVALUATING DELAYED FLUORESCENCE MATERIAL, METHOD FOR DESIGNING DELAYED FLUORESCENCE MATERIAL, METHOD FOR DESIGNING ORGANIC LIGHT-EMITTING ELEMENT, AND PROGRAM

MATERIALS FOR ELECTRONIC DEVICES

ZWITTERIONIC ANTIBACTERIAL COMPOUNDS

RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF

Substituted 2-(pyrrolidine-3-yl)acetic acid derivative, preparation method and use thereof

PYRIMIDINLY-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS

NEW ANTIVIRAL TRIAZOLE DERIVATIVES, THEIR SYNTHESIS AND THEIR USE FOR TREATMENT OF MAMMALIAN VIRAL INFECTIONS

POLO-LIKE KINASE 4 (PLK4) INHIBITORS, PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

COMPOUNDS, COMPOSITIONS, AND METHODS

HETEROCYCLIC COMPOUNDS AND USES THEREOF

INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES

HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF

AZA-HETEROCYCLYL CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

PYRROLIDINE COMPOUNDS

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

ALLOSTERIC STING MODULATORS AND METHODS OF USE

CBL-B MODULATORS AND USES THEREOF

NOVEL MOLECULES AS INHIBITORS OF DNA DAMAGE REPAIR PATHWAY

BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES

PYRIDIZIN-3(2H)-ONE DERIVATIVES

PYRIDONE OR PYRIMIDONE DERIVATIVE AND APPLICATION THEREOF

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

COMPOUNDS AND METHODS FOR MODULATING SPLICING

GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

COMPOUND AS FAK INHIBITOR AND USE THEREOF

COVALENT INHIBITORS OF KRAS

MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN

SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE

KHK INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

ACID CERAMIDASE INHIBITORS AND USES THEREOF

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

C-LINKED INHIBITORS OF ENL/AF9 YEATS

SELECT KRAS G12C INHIBITORS AND USES THEREOF

SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

ERBB2 INHIBITORS

BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS

HERBICIDAL IMIDAZOLE COMPOUNDS

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF

ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES

COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF

POLYHETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS

BENZIMIDAZOLES AS MODULATORS OF IL-17

INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

Protease Inhibitors as Antivirals

Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound

TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF

PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS

BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

AROMATIC FUSED RING NAV1.8 INHIBITOR, AND USE THEREOF

2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD

CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS

TRIAZOLYL CROSS-LINKING AGENT AS WELL AS PREPARATION METHOD AND USE THEREOF

SQUARAINE FLUOROPHORES

CYANINE DYES AND THEIR BIOLOGICAL CONJUGATES

PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS

PARP7 INHIBITORS

Anticancer Compounds, Pharmaceutical Compositions, and Methods of Treating Cancers

HETEROCYCLIC COMPOUNDS

Trialkyne Linking Agents and Methods of Use

2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS

TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER

GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

PIPERAZINE INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS

MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE

INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS

TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS

INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

SALT FORM AND CRYSTAL FORM OF TETRAHYDROCYCLOHEPTA INDAZOLE COMPOUND

NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

COMPOUNDS AND METHODS FOR MODULATING SPLICING

ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS

PYRIDAZINONES AS PARP7 INHIBITORS

HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME

PARP7 INHIBITORS

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors